These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8779117)

  • 1. [The use of nimodipine in elderly dementia patients].
    Damulin IV; Levin OS; Zakharov VV; Zhuchenko TD; Elkin MN
    Ter Arkh; 1995; 67(10):77-9. PubMed ID: 8779117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
    Fritze J; Walden J
    J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta ; Birks J
    Cochrane Database Syst Rev; 2001; (1):CD000147. PubMed ID: 11279679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2000; 2002(2):CD000147. PubMed ID: 10796495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of nimodipine in treatment of dementia].
    Eckert A
    Pharm Unserer Zeit; 2005; 34(5):392-8. PubMed ID: 16180362
    [No Abstract]   [Full Text] [Related]  

  • 8. Nimodipine in subcortical vascular dementia trial.
    Rossi R; Inzitari D; Pantoni L; del Ser T; Erkinjuntti T; Wallin A; Bianchi C; Badenas JM; Beneke M
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S159-65. PubMed ID: 10609696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of piracetam with nimodipine on vascular dementia after cerebral infarction.
    Zongfang Z; Wenjing L; Zhaomin C; Lei Z
    Pak J Pharm Sci; 2020 Sep; 33(5(Special)):2405-2411. PubMed ID: 33832882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group.
    Parnetti L; Senin U; Carosi M; Baasch H
    Clin Ther; 1993; 15(2):394-406. PubMed ID: 8519047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging, dementia and calcium metabolism.
    Kanowski S
    J Neural Transm Suppl; 1998; 54():195-200. PubMed ID: 9850928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivastigmine for subcortical vascular dementia.
    Román GC
    Expert Rev Neurother; 2005 May; 5(3):309-13. PubMed ID: 15938663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM; Lyons D; Shin IS; Yoon JS
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.
    Pantoni L; Rossi R; Inzitari D; Bianchi C; Beneke M; Erkinjuntti T; Wallin A
    J Neurol Sci; 2000 Apr; 175(2):124-34. PubMed ID: 10831773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Altered calcium homeostasis in brain aging and senile dementia, new approach to treat Alzheimer's disease].
    Zhang JT
    Yao Xue Xue Bao; 1993; 28(9):641-6. PubMed ID: 8010007
    [No Abstract]   [Full Text] [Related]  

  • 16. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP; Bayer AJ; Steinhagen-Thiessen E
    J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of perospirone on aggressive behavior associated with dementia.
    Sato S; Mizukami K; Moro K; Tanaka Y; Asada T
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):106-9. PubMed ID: 16472367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia].
    Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.